NCT05086939 - Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis. | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2026

Conditions

Knee Osteoarthritis

Interventions

DRUG

Autologous MSCs

Intra-articular injection 40 million/4 ml.

DRUG

Allogenic MSCs

Intra-articular injection 40 million/4 ml.

DRUG

Hyaluronic Acid

Intra-articular injection 60mg / 3 ml .

Trial Locations (8)

37007

Complejo Asistencial Universitario de Salamanca, Salamanca

Unknown

Hospital Clinic, Barcelona

Hospital Clínico Universitario San Carlos, Madrid

Hospital Fundación Jiménez Díaz, Madrid

Hospital Gregorio Marañón, Madrid

Hospital Universitario Virgen de la Victoria, Málaga

Hospital Universitario Virgen de la Arrixaca, Murcia

Clínica Universidad de Navarra, Pamplona

All Listed Sponsors

collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Spanish Clinical Research Network - SCReN

NETWORK

collaborator

Institut d'Investigacions Biomèdiques August Pi i Sunyer

OTHER

collaborator

Hospital Universitari de Bellvitge

OTHER

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER